<p>According to Wu Shuo, PR Newswire reports that the American biopharmaceutical company Hoth Therapeutics, Inc. has announced that its board of directors has approved the purchase of up to 1 million USD worth of Bitcoin. Hoth's CEO Robb Knie stated, "We believe that Bitcoin will become a powerful financial reserve asset. The anti-inflation characteristics of Bitcoin may make it a reliable asset with value storage capabilities."</p>

<div> 

		Wu said, according to PR Newswire, that the American biopharmaceutical company Hoth Therapeutics, Inc. announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated, "We believe that Bitcoin will become a powerful financial reserve asset. Its anti-inflation characteristics may make it a reliable asset with value storage functions." 
<div> </div><br/><br/></div>

Hoth Therapeutics' board approved the purchase of 1 million USD worth of Bitcoin as reserve assets.